In a report released today, Neil Chatterji from B.Riley Financial maintained a Buy rating on Stereotaxis (STXS – Research Report), with a price target of $4.50. The company’s shares closed yesterday at $2.02.
Chatterji covers the Healthcare sector, focusing on stocks such as Stereotaxis, OptimizeRx, and Silk Road Medical. According to TipRanks, Chatterji has an average return of 3.8% and a 50.00% success rate on recommended stocks.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Stereotaxis with a $4.50 average price target, which is a 122.77% upside from current levels. In a report released today, Piper Sandler also maintained a Buy rating on the stock with a $5.00 price target.
See Insiders’ Hot Stocks on TipRanks >>
The company has a one-year high of $2.75 and a one-year low of $1.55. Currently, Stereotaxis has an average volume of 272.2K.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Stereotaxis, Inc. engages in the design, manufacture, and market of robotic systems and instruments that electrophysiologists use for the treatment of abnormal heart rhythms known as cardiac arrhythmias. Its products include The Epoch Solution, Niobe Magnetic Navigation System, Vdrive Robotic Navigation System, and Odyssey Solution. The company was founded in June 1990 and is headquartered in St. Louis, MO.
Read More on STXS:
- Stereotaxis to Initiate First-in-Human Trial to Support CE Mark Application of MAGiC Catheter
- Stereotaxis to Participate in 20th Annual Craig-Hallum Institutional Investor Conference
- Advocate Christ Medical Center Extends Leadership in Heart Care with Adoption of Genesis Robotic Technology
- Stereotaxis and Abbott Announce Global Collaboration Combining Leading Mapping and Robotic Technologies to Improve Treatment of Abnormal Heart Rhythms
- Stereotaxis Reports 2023 First Quarter Financial Results
